Delivery Order SPE2DR25D1053-SPE2DR26FV632
- Not listed
- The Defense Logistics Agency awarded a $6,211.30 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of January 20, 2026, represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 through December 2031, serves...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,912.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. The contract, awarded on January 14, 2026, with an ultimate completion date of January 15, 2026, utilizes firm fixed-price pricing and represents a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with the work to be performed at its...
- The Defense Logistics Agency awarded a delivery order valued at $14,040.64 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,999.38 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and...
- The Defense Logistics Agency awarded a $16,550.52 delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 8, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed-price contract is scheduled for completion by January 9, 2026, and will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, indicating the award was made through full...
- The Defense Logistics Agency awarded a $41,246.60 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with a completion date of December 4, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at approximately $46,000 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors, with performance completion targeted for January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency awarded a $36,284.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of December 18, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $33,486.51 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price, non-set-aside contract was executed on January 8, 2026, with an ultimate completion date of January 9, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $3,776.73 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 3, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV632Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,243.16 to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on January 16, 2026, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 20, 2026, and performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. Repatha (evolocumab) is a PCSK9 inhibitor used for treatment of high cholesterol in patients who cannot achieve adequate control through statins alone, making it a critical specialty pharmaceutical for military healthcare beneficiaries with cardiovascular risk factors. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain capabilities and established relationship with the Defense Logistics Agency to deliver brand-name medications across multiple therapeutic domains. The rapid completion timeline reflects the urgent nature of this medical supply requirement for military treatment facilities and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.2k | 1/15/26 |